MANAGEMENT OF HIGH-RISK CHRONIC MYELOID LEUKEMIA IN TYROSINE KINASE INHIBITOR RESISTANCE: A SYSTEMATIC REVIEW IM de Almeida, LM Pinheiro, CM Lucini, MFGM Fernandes, LBL Moraes, J Tessa, JWO Romanov

DISCONTINUATION OF TYROSINE KINASE INHIBITORS IN TUNISIAN CHRONIC MYELOID LEUKEMIA PATIENTS Rim FRIKHA, Moez ELLOUMI, Hassen KAMOUN

Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice Carla Boquimpani, Fernanda Salles Seguro, Gustavo Henrique Romani Magalhães, Ingrid Luise Soares Pinto, Israel Bendit, Jaisson André Pagnoncelli Bortolini, Katia Borgia Barbosa Pagnano, Renato Centrone, Vaneuza Funke